ERAS
Price
$1.44
Change
-$0.07 (-4.67%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
405.1M
Earnings call today
OCUL
Price
$12.49
Change
+$0.49 (+4.08%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
2.17B
95 days until earnings call
Interact to see
Advertisement

ERAS vs OCUL

Header iconERAS vs OCUL Comparison
Open Charts ERAS vs OCULBanner chart's image
Erasca
Price$1.44
Change-$0.07 (-4.67%)
Volume$22.47K
Capitalization405.1M
Ocular Therapeutix
Price$12.49
Change+$0.49 (+4.08%)
Volume$37.54K
Capitalization2.17B
ERAS vs OCUL Comparison Chart in %
Loading...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERAS vs. OCUL commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a StrongBuy and OCUL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (ERAS: $1.43 vs. OCUL: $12.50)
Brand notoriety: ERAS and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 64% vs. OCUL: 117%
Market capitalization -- ERAS: $405.1M vs. OCUL: $2.17B
ERAS [@Biotechnology] is valued at $405.1M. OCUL’s [@Biotechnology] market capitalization is $2.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • ERAS’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ERAS and OCUL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 5 TA indicator(s) are bullish while OCUL’s TA Score has 3 bullish TA indicator(s).

  • ERAS’s TA Score: 5 bullish, 5 bearish.
  • OCUL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ERAS is a better buy in the short-term than OCUL.

Price Growth

ERAS (@Biotechnology) experienced а -7.74% price change this week, while OCUL (@Biotechnology) price change was +7.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.54%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +13.42%.

Reported Earning Dates

ERAS is expected to report earnings on Nov 05, 2025.

OCUL is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (-0.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($2.18B) has a higher market cap than ERAS($405M). OCUL YTD gains are higher at: 46.370 vs. ERAS (-43.028). ERAS has higher annual earnings (EBITDA): -150.24M vs. OCUL (-176.35M). OCUL has more cash in the bank: 350M vs. ERAS (305M). ERAS has less debt than OCUL: ERAS (50.8M) vs OCUL (76.2M). OCUL has higher revenues than ERAS: OCUL (59.6M) vs ERAS (0).
ERASOCULERAS / OCUL
Capitalization405M2.18B19%
EBITDA-150.24M-176.35M85%
Gain YTD-43.02846.370-93%
P/E RatioN/AN/A-
Revenue059.6M-
Total Cash305M350M87%
Total Debt50.8M76.2M67%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ERASOCUL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KNGLX11.610.03
+0.26%
Vest S&P500 Div Aristocrats Trgt Inc Inv
FIADX56.18N/A
N/A
Fidelity Advisor International Discv I
MWEGX38.80N/A
N/A
MFS Global Equity R1
HGHFX35.72N/A
N/A
Hartford Healthcare F
BGCSX15.40N/A
N/A
Baillie Gifford EAFE Plus All Cap I